Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100PKQH
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥5.8bn2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥2.8bn2021-04-01 → 2021-09-30StandaloneNet sales
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income¥226m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥506m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥223m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥221m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income¥328m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income¥145m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥2.8bnat 2022-09-30StandaloneAssets
Total assets¥2.5bnat 2022-03-31StandaloneAssets
Total assets¥2.2bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥1.5bnat 2022-09-30StandaloneLiabilities
Total liabilities¥1.5bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets
Net assets / equity¥1.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥755mat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥680mat 2022-09-30StandaloneCash and deposits
Cash and deposits¥720mat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥561mat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥538mat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥485m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥177m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥320m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥172m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥17m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥18m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥50.662022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.512022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥95.82021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥42.632021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥20.812021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥47.472022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥88.282021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio33.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,499,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued11,369at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥39m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥199m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥11m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥329m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥25m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥25m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2022-04-01 → 2022-09-30−¥8m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥160m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥492m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥454m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥8m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥154m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥62m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥62m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentsegment profit2021-04-01 → 2021-09-30−¥849,000
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥2.5bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥2.5bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2021-04-01 → 2021-09-30¥262m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥37m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥37m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2021-04-01 → 2021-09-30¥14m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2021-04-01 → 2021-09-30¥192m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2021-04-01 → 2021-09-30¥192m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2021-04-01 → 2021-09-30¥114m
—segment totalrevenue2021-04-01 → 2021-09-30¥2.8bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥2.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥388m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥380m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 437
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)宮　本　芳　樹
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)下　平　雅　和
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember2767773000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember3168844000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember5782604000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember223349000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember263470000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember506182000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember145390000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember178862000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember328454000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember104742000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember185220000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember171915000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember11369
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember3568400
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember3499100
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember754854000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1277738000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1072264000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember2235363000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember2751099000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember2531605000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember42.63
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember50.66
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember95.80
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember－
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember47.47
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember88.28
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember－
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.338
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.464
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.424
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember176525000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember96723000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration_NonConsolidatedMember484597000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember-172337000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember-193145000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember-320255000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember18376000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember56823000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember16927000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass